| NCT Number | NCT05363046 |
| Lead Sponsor | BlueRock Therapeutics |
| Conditions | Parkinson's Disease |
| Enrollment | 194 participants |
| Start Date | 2022-07-29 |
| Primary Completion | 2025-10 (estimated) |
| Study Completion | 2026-10 (estimated) |
| Updated on ClinicalTrials.gov | 2024-07-31 |